A 58-year-old cisgender man who was diagnosed with HIV 10 years ago is seen in a clinic for a routine appointment. He has taken efavirenz-tenofovir DF-emtricitabine for approximately 8 years, and he consistently has an undetectable HIV RNA level. He has a significant past history of opiate use disorder and takes methadone 60 mg once daily via a methadone program. During the past 3 months, he has developed some depression, and the plan at this visit is to switch the antiretroviral regimen to bictegravir-tenofovir alafenamide-emtricitabine.
Following the change in antiretroviral therapy, which one of the following would be expected regarding methadone levels during the subsequent several weeks?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
August 28th, 2024
August 28th, 2024
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5